The North America stem cell assay market has witnessed significant growth in recent years, driven by increased investment in stem cell research, advances in biotechnology, and growing applications of stem cells in various medical fields. As of 2023, the market was valued at approximately USD 7.1 billion and is expected to expand at a robust compound annual growth rate (CAGR) of 10.08% from 2024...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek